光动力疗法联合玻璃体内注射曲安奈德治疗病理性近视继发脉络膜新生血管：一项前瞻性研究。
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
作者信息
Montero Javier A, Ruiz-Moreno Jose M
出版信息
Br J Ophthalmol. 2007 Feb;91(2):131-3. doi: 10.1136/bjo.2006.106526.
Abstract
Intravitreous triamcinolone associated with PDT should preferably be used among elderly patients who usually show lower visual acuity and a poorer response to PDT, or among patients with recurrent or greater CNVs
摘要
对于通常视力较低且对光动力疗法（PDT）反应较差的老年患者，或对于复发性或较大脉络膜新生血管（CNV）患者，玻璃体内注射曲安奈德联合PDT可能是更优选择。
相似文献
1
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.光动力疗法联合玻璃体内注射曲安奈德治疗病理性近视继发脉络膜新生血管：一项前瞻性研究。
Br J Ophthalmol. 2007 Feb;91(2):131-3. doi: 10.1136/bjo.2006.106526.
2
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.光动力疗法联合玻璃体内注射曲安奈德治疗病理性近视继发脉络膜新生血管：一项初步研究。
Br J Ophthalmol. 2007 Feb;91(2):174-9. doi: 10.1136/bjo.2006.103606. Epub 2006 Sep 20.
3
Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.光动力疗法联合玻璃体内注射曲安奈德治疗近视性脉络膜新生血管。
Acta Ophthalmol Scand. 2005 Oct;83(5):621. doi: 10.1111/j.1600-0420.2005.00506.x.
4
Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.联合光动力疗法与玻璃体内注射曲安奈德治疗一名13岁女孩的近视性脉络膜新生血管
Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):639-41. doi: 10.1007/s00417-005-0115-3. Epub 2005 Sep 21.
5
Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.光动力疗法联合玻璃体内注射曲安奈德治疗近视性黄斑下脉络膜新生血管
Am J Ophthalmol. 2006 Aug;142(2):335-7. doi: 10.1016/j.ajo.2006.03.003.
6
Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.维替泊芬光动力疗法联合玻璃体内注射曲安奈德治疗脉络膜新生血管。
Ophthalmology. 2005 Feb;112(2):301-4. doi: 10.1016/j.ophtha.2004.08.012.
7
Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization.光动力疗法联合玻璃体内注射曲安奈德治疗非黄斑中心凹下脉络膜新生血管
Retina. 2005 Sep;25(6):685-90. doi: 10.1097/00006982-200509000-00001.
8
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.维替泊芬疗法联合玻璃体内注射曲安奈德治疗年龄相关性黄斑变性所致的所有类型脉络膜新生血管。
Ophthalmology. 2006 Jan;113(1):14-22. doi: 10.1016/j.ophtha.2005.09.002. Epub 2005 Dec 19.
9
The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.光动力疗法联合玻璃体内注射曲安奈德（TA）治疗年龄相关性黄斑变性继发隐匿性脉络膜新生血管的疗效。
Retina. 2006 Jul-Aug;26(6):714; author reply 715. doi: 10.1097/01.iae.0000236477.09561.d6.
10
Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide.
Retina. 2005 Apr-May;25(3):377-9. doi: 10.1097/00006982-200504000-00024.
引用本文的文献
1
A systematic review of clinical practice guidelines for myopic macular degeneration.近视性黄斑变性的临床实践指南系统评价。
J Glob Health. 2022 Mar 26;12:04026. doi: 10.7189/jogh.12.04026. eCollection 2022.
2
The Features of Inflammation Factors Concentrations in Aqueous Humor of Polypoidal Choroidal Vasculopathy.息肉样脉络膜血管病变房水中炎症因子浓度的特征
PLoS One. 2016 Jan 22;11(1):e0147346. doi: 10.1371/journal.pone.0147346. eCollection 2016.
3
Single intravitreal ranibizumab for myopic choroidal neovascularization.单次玻璃体内注射雷珠单抗治疗近视性脉络膜新生血管
Clin Ophthalmol. 2011;5:1079-82. doi: 10.2147/OPTH.S21057. Epub 2011 Apr 8.
4
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia.光动力单一疗法或联合治疗与玻璃体内曲安奈德、贝伐单抗或雷珠单抗治疗病理性近视相关脉络膜新生血管。
Indian J Ophthalmol. 2011 May-Jun;59(3):242-6. doi: 10.4103/0301-4738.81049.
5
Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.玻璃体内注射贝伐单抗治疗近视性脉络膜新生血管：两种不同初始剂量的比较。
Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):595-9. doi: 10.1007/s00417-010-1599-z. Epub 2011 Jan 14.
6
Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization.玻璃体内注射雷珠单抗（Lucentis）治疗近视性脉络膜新生血管。
Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):311-8. doi: 10.1007/s00417-008-0995-0. Epub 2008 Nov 29.
本文引用的文献
1
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.光动力疗法联合玻璃体内注射曲安奈德治疗病理性近视继发脉络膜新生血管：一项初步研究。
Br J Ophthalmol. 2007 Feb;91(2):174-9. doi: 10.1136/bjo.2006.103606. Epub 2006 Sep 20.
2
Evolving European guidance on the medical management of neovascular age related macular degeneration.不断发展的欧洲关于新生血管性年龄相关性黄斑变性医疗管理的指南。
Br J Ophthalmol. 2006 Sep;90(9):1188-96. doi: 10.1136/bjo.2005.082255.
3
Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.玻璃体内注射贝伐单抗治疗病理性近视相关脉络膜新生血管化
Br J Ophthalmol. 2007 Feb;91(2):161-5. doi: 10.1136/bjo.2006.099887. Epub 2006 Aug 16.
4
Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.光动力疗法联合玻璃体内注射曲安奈德治疗近视性黄斑下脉络膜新生血管
Am J Ophthalmol. 2006 Aug;142(2):335-7. doi: 10.1016/j.ajo.2006.03.003.
5
Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗病理性近视继发的黄斑下脉络膜新生血管化
Br J Ophthalmol. 2007 Feb;91(2):157-60. doi: 10.1136/bjo.2006.096776. Epub 2006 Jul 26.
6
Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.光动力疗法与高剂量玻璃体内注射曲安奈德治疗渗出性年龄相关性黄斑变性：1年随访结果
Retina. 2006 Jul-Aug;26(6):602-12. doi: 10.1097/01.iae.0000224942.59481.c9.
7
Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.维替泊芬联合玻璃体腔注射曲安奈德光动力疗法治疗新生血管性年龄相关性黄斑变性
Am J Ophthalmol. 2006 Jul;142(1):10-16. doi: 10.1016/j.ajo.2006.02.048.
8
Indocyanine green angiographic features of myopic subfoveal choroidal neovascularization as a prognostic factor after photodynamic therapy.
Korean J Ophthalmol. 2006 Mar;20(1):18-25. doi: 10.3341/kjo.2006.20.1.18.
9
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.息肉样脉络膜血管病变和脉络膜新生血管中血管内皮生长因子和色素上皮衍生因子的房水水平。
Am J Ophthalmol. 2006 Mar;141(3):456-62. doi: 10.1016/j.ajo.2005.10.012.
10
National survey of the technique of intravitreal triamcinolone injection in the United Kingdom.英国玻璃体内注射曲安奈德技术的全国性调查。
Eye (Lond). 2007 Apr;21(4):480-6. doi: 10.1038/sj.eye.6702232. Epub 2006 Jan 27.
Zotero 插件